guest ::
| Home > Publications database > Targeting aldolase A in hepatocellular carcinoma leads to imbalanced glycolysis and energy stress due to uncontrolled FBP accumulation. > print |
| Home > Publications database > Targeting aldolase A in hepatocellular carcinoma leads to imbalanced glycolysis and energy stress due to uncontrolled FBP accumulation. > print |
| 001 | 298171 | ||
| 005 | 20250226160325.0 | ||
| 024 | 7 | _ | |a 10.1038/s42255-024-01201-w |2 doi |
| 024 | 7 | _ | |a pmid:39833612 |2 pmid |
| 024 | 7 | _ | |a altmetric:173187150 |2 altmetric |
| 037 | _ | _ | |a DKFZ-2025-00190 |
| 041 | _ | _ | |a English |
| 082 | _ | _ | |a 610 |
| 100 | 1 | _ | |a Snaebjörnsson, Marteinn Thor |0 P:(DE-He78)7b7131e0870c28d432e48873d295460f |b 0 |e First author |u dkfz |
| 245 | _ | _ | |a Targeting aldolase A in hepatocellular carcinoma leads to imbalanced glycolysis and energy stress due to uncontrolled FBP accumulation. |
| 260 | _ | _ | |a [London] |c 2025 |b Springer Nature |
| 336 | 7 | _ | |a article |2 DRIVER |
| 336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
| 336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1740582169_18639 |2 PUB:(DE-HGF) |
| 336 | 7 | _ | |a ARTICLE |2 BibTeX |
| 336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
| 336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
| 500 | _ | _ | |a #EA:A410#LA:A410# / 2025 Feb;7(2):348-366 |
| 520 | _ | _ | |a Increased glycolytic flux is a hallmark of cancer; however, an increasing body of evidence indicates that glycolytic ATP production may be dispensable in cancer, as metabolic plasticity allows cancer cells to readily adapt to disruption of glycolysis by increasing ATP production via oxidative phosphorylation. Using functional genomic screening, we show here that liver cancer cells show a unique sensitivity toward aldolase A (ALDOA) depletion. Targeting glycolysis by disrupting the catalytic activity of ALDOA led to severe energy stress and cell cycle arrest in murine and human hepatocellular carcinoma cell lines. With a combination of metabolic flux analysis, metabolomics, stable-isotope tracing and mathematical modelling, we demonstrate that inhibiting ALDOA induced a state of imbalanced glycolysis in which the investment phase outpaced the payoff phase. Targeting ALDOA effectively converted glycolysis from an energy producing into an energy-consuming process. Moreover, we found that depletion of ALDOA extended survival and reduced cancer cell proliferation in an animal model of hepatocellular carcinoma. Thus, our findings indicate that induction of imbalanced glycolysis by targeting ALDOA presents a unique opportunity to overcome the inherent metabolic plasticity of cancer cells. |
| 536 | _ | _ | |a 311 - Zellbiologie und Tumorbiologie (POF4-311) |0 G:(DE-HGF)POF4-311 |c POF4-311 |f POF IV |x 0 |
| 588 | _ | _ | |a Dataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de |
| 700 | 1 | _ | |a Poeller, Philipp |0 0000-0002-3924-5756 |b 1 |
| 700 | 1 | _ | |a Komkova, Daria |b 2 |
| 700 | 1 | _ | |a Röhrig, Florian |b 3 |
| 700 | 1 | _ | |a Schlicker, Lisa |0 P:(DE-He78)e52c8f6ae826320eaf2fb173e162070d |b 4 |
| 700 | 1 | _ | |a Winkelkotte, Alina |0 P:(DE-He78)a2efd829a4ed4177427f4ceeafa06a3c |b 5 |u dkfz |
| 700 | 1 | _ | |a Chaves-Filho, Adriano B |0 P:(DE-HGF)0 |b 6 |
| 700 | 1 | _ | |a Al-Shami, Kamal M |0 P:(DE-He78)b7a0487a60da451c67d4b0fef6641ed8 |b 7 |u dkfz |
| 700 | 1 | _ | |a Caballero, Carolina Dehesa |0 P:(DE-HGF)0 |b 8 |
| 700 | 1 | _ | |a Koltsaki, Ioanna |0 P:(DE-He78)b2c36a9237b50f6e89390cb22a073910 |b 9 |u dkfz |
| 700 | 1 | _ | |a Vogel, Felix Christian Eduard |0 P:(DE-He78)38900a0e1ae96a725db546cb7b909adb |b 10 |u dkfz |
| 700 | 1 | _ | |a Frias-Soler, Roberto Carlos |0 0000-0003-0942-9463 |b 11 |
| 700 | 1 | _ | |a Rudalska, Ramona |0 0000-0002-1742-0912 |b 12 |
| 700 | 1 | _ | |a Schwarz, Jessica D |b 13 |
| 700 | 1 | _ | |a Wolf, Elmar |b 14 |
| 700 | 1 | _ | |a Dauch, Daniel |b 15 |
| 700 | 1 | _ | |a Steuer, Ralf |b 16 |
| 700 | 1 | _ | |a Schulze, Almut |0 P:(DE-He78)94ae391f53fb9285e1b68f9930615af1 |b 17 |e Last author |u dkfz |
| 773 | _ | _ | |a 10.1038/s42255-024-01201-w |0 PERI:(DE-600)2933873-6 |n 2 |p 348-366 |t Nature metabolism |v 7 |y 2025 |x 2522-5812 |
| 909 | C | O | |p VDB |o oai:inrepo02.dkfz.de:298171 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 0 |6 P:(DE-He78)7b7131e0870c28d432e48873d295460f |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 1 |6 0000-0002-3924-5756 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 4 |6 P:(DE-He78)e52c8f6ae826320eaf2fb173e162070d |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 5 |6 P:(DE-He78)a2efd829a4ed4177427f4ceeafa06a3c |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 6 |6 P:(DE-HGF)0 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 7 |6 P:(DE-He78)b7a0487a60da451c67d4b0fef6641ed8 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 8 |6 P:(DE-HGF)0 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 9 |6 P:(DE-He78)b2c36a9237b50f6e89390cb22a073910 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 10 |6 P:(DE-He78)38900a0e1ae96a725db546cb7b909adb |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 11 |6 0000-0003-0942-9463 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 17 |6 P:(DE-He78)94ae391f53fb9285e1b68f9930615af1 |
| 913 | 1 | _ | |a DE-HGF |b Gesundheit |l Krebsforschung |1 G:(DE-HGF)POF4-310 |0 G:(DE-HGF)POF4-311 |3 G:(DE-HGF)POF4 |2 G:(DE-HGF)POF4-300 |4 G:(DE-HGF)POF |v Zellbiologie und Tumorbiologie |x 0 |
| 914 | 1 | _ | |y 2025 |
| 915 | _ | _ | |a DEAL Nature |0 StatID:(DE-HGF)3003 |2 StatID |d 2024-12-16 |w ger |
| 915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b NAT METAB : 2022 |d 2024-12-16 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |d 2024-12-16 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |d 2024-12-16 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Clarivate Analytics Master Journal List |d 2024-12-16 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1050 |2 StatID |b BIOSIS Previews |d 2024-12-16 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0160 |2 StatID |b Essential Science Indicators |d 2024-12-16 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1030 |2 StatID |b Current Contents - Life Sciences |d 2024-12-16 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1190 |2 StatID |b Biological Abstracts |d 2024-12-16 |
| 915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0113 |2 StatID |b Science Citation Index Expanded |d 2024-12-16 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |d 2024-12-16 |
| 915 | _ | _ | |a IF >= 20 |0 StatID:(DE-HGF)9920 |2 StatID |b NAT METAB : 2022 |d 2024-12-16 |
| 920 | 2 | _ | |0 I:(DE-He78)A410-20160331 |k A410 |l Metabolismus und Microenvironment |x 0 |
| 920 | 1 | _ | |0 I:(DE-He78)A410-20160331 |k A410 |l Metabolismus und Microenvironment |x 0 |
| 920 | 0 | _ | |0 I:(DE-He78)A410-20160331 |k A410 |l Metabolismus und Microenvironment |x 0 |
| 980 | _ | _ | |a journal |
| 980 | _ | _ | |a VDB |
| 980 | _ | _ | |a I:(DE-He78)A410-20160331 |
| 980 | _ | _ | |a UNRESTRICTED |
| Library | Collection | CLSMajor | CLSMinor | Language | Author |
|---|